Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-09

Clinical Trial Update: Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Avexitide evaluating safety and efficacy in acquired hyperinsulinemic hypoglycemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avexitide

Snippet

Sponsor: Dr. Tracey McLaughlin, MD | Conditions: Acquired Hyperinsulinemic Hypoglycemia | Phase 2 | Status: COMPLETED | Results posted: 2023-06-09